For example, cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) (Li et al., 2018; Sharma, 2019; Marucci et al., 2021) and the NMDA receptor (Ahmed et al., 2020) antagonist memantine for AD, levodopa (L-DOPA) administration for PD (Teymourian et al., 2022), and transcranial magnetic stimulation (TMS) as a non-invasive non-pharmacological method for many kinds of NDs (Ni and Chen, 2015). Here, BCHE is linked to Parkinson disease.